Announcement under Regulation 30 (LODR) - Change in Management
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Reddy's Board meeting on May 12, 2026 approved several governance changes. Key appointments include re-appointment of Dr. K.P. Krishnan as Independent Director for a second 5-year term (Jan 2027 - Jan 2032) and new appointment of Mr. Srikanth Velamakanni (Co-Founder and Group CEO of Fractal, India's first listed pure-play AI company) as Independent Director for 5 years (July 2026 - June 2031). The Board also appointed Deloitte Haskins & Sells LLP as the new Statutory Auditors for a 5-year term starting from the 42nd AGM, replacing the previous auditors. M/s Sagar & Associates was re-appointed as Cost Auditors for FY 2026-27. Additionally, Mr. Sandeep Khandelwal, Global Generics India Head, was elevated to Senior Management Personnel and inducted into the Management Council, effective immediately. Sandeep has been with Dr. Reddy's since 2018 and has grown the India business from Rs 2,300 crore to Rs 7,000 crore.
The changes appear routine and governance-friendly. New independent directors bring strong external expertise in public policy/economics and AI/technology. The auditor change is likely part of mandatory rotation. Internal promotion of a high-performing business leader signals continuity and internal succession planning. Minimal shareholder concern expected.